1 Thing That Can Kill Best Buy Co., Inc. (BBY)

Page 1 of 2

This is going to be an important week for three of retail’s biggest laggards.

RadioShack Corporation (NYSE:RSH), Best Buy Co., Inc. (NYSE:BBY), and Barnes & Noble, Inc. (NYSE:BKS) will all report on their holiday quarters this week.

It’s not supposed to be pretty.

Best Buy Co., Inc. (NYSE:BBY)RadioShack is eyeing its fourth consecutive quarterly deficit when it reports tomorrow, and the market doesn’t know if the strip mall chain will ever turn a profit again. The shift from traditional consumer electronics to an emphasis on smartphones has crushed margins.

Barnes & Noble is only rallying today on buyout news. The company itself is a mess, and analysts see a sharp decline in profitability as net sales dip slightly when it reports on Thursday.

Best Buy, by comparison, is a brazen beauty.

Analysts see a 38% plunge in profitability on a 2% decline in net sales. Best Buy may have eased investors fears last month by announcing flat holiday sales, but the company’s appliance chain in China is sputtering and January probably wasn’t a treat given the end of the 2% payroll tax stimulus plan.

However, Best Buy’s in a good groove these days. The stock has been one of the bigger winners of 2013, up a healthy 44% so far this year.

The market’s wondering if disappointed founder Richard Schulze may be making another play for the struggling retailer, and the market even applauded the store operator’s move to price-match Amazon.com, Inc. (NASDAQ:AMZN) — and a handful of other online retailers — all year round starting next Sunday.

The move to beef up Best Buy’s Low Price Guarantee is interesting. The chain is calling this end of “showrooming,” but it may very well be the end of margin expansion. Matching Amazon.com and 18 other online retailers will result in Best Buy selling at prices that may be unrealistic for a brick-and-mortar chain to support given its cost structures.

As more customers use their smartphones to pull up prices — and the lines at customer service grow longer — it won’t come as a surprise to see earnings continue to head lower despite any growth in net sales.

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!